Construction of a nanozyme composite drug delivery system based on columbianadin for inflammatory bowel disease therapy

Key Points

• The aim is to create a novel drug delivery system using nanozymes to specifically target inflammatory bowel disease.
• Developed a composite hydrogel using MXene, columbianadin, and GelMA.
• Applied targeted formulation techniques to enhance drug delivery efficacy.
• Conducted evaluations of the hydrogel's therapeutic potential in simulated environments.
• Demonstrated effectiveness of the MXene/CBN@GelMA composite in targeting inflammation.
• Showed improved drug delivery capabilities compared to conventional methods.